 Connection
John Rumsfeld to Drug Labeling
This is a "connection" page, showing publications John Rumsfeld has written about Drug Labeling.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.050 |
|
|
|
-
Barnes GD, Stanislawski MA, Liu W, Bar?n AE, Armstrong EJ, Ho PM, Klein A, Maddox TM, Nallamothu BK, Rumsfeld JS, Tsai TT, Bradley SM. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2016 07; 9(4):406-13.
Score: 0.032
-
Ting HH, Roe MT, Gersh BJ, Spertus JA, Rumsfeld JS, Ou FS, Kao J, Long KH, Holmes DR, Peterson ED. Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol. 2008 Feb 01; 101(3):286-92.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|